Additionally, the analyses regarding DFS stratified by detection methods revealed was also conducted and revealed an unfavorable DFS in breast cancer patients with YKL-40 overexpression evaluated both by IHC and by ELISA/RIA without observed heterogeneity. The gene discussed is CHI3L1; the disease is breast cancer.